Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared?

Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these... Ann Surg Oncol (2019) 26:8–9 https://doi.org/10.1245/s10434-018-7067-4 EDITORIAL – MELANOMA Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared? 1,2 1,3,4 Hidde M. Kroon, MD, PhD and John F. Thompson, MD, FRACS, FACS 1 2 Melanoma Institute Australia, The University of Sydney, North Sydney, NSW,Australia; Department of General Surgery, The University of Adelaide, Royal Adelaide Hospital, Adelaide, SA, Australia; Discipline of Surgery, The University of Sydney, Sydney, NSW, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia When bulky or numerous local melanoma recurrences or locally recurrent or in-transit metastatic melanoma in-transit melanoma metastases develop in a limb, simple involving a limb. Furthermore, both procedures have local treatment modalities such as excision, cryotherapy, acceptable, usually minor, locoregional postoperative tox- laser ablation, or intralesional injection with Rose Bengal icity with a short hospital stay. Overall responses of (PV-10) or talimogene laherparepvec (T-VEC) are likely to 64–96% can be achieved after ILP, while, in large ILI be ineffective or simply not possible. However, achieving series, overall response rates of 43–84% have been repor- adequate disease control is important in these patients as ted, with somewhat lower complete response rates http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared?

Annals of Surgical Oncology, Volume 26 (1) – Nov 21, 2018

Loading next page...
 
/lp/springer-journals/isolated-limb-infusion-and-isolated-limb-perfusion-for-melanoma-can-nRF28tmF6G
Publisher
Springer Journals
Copyright
Copyright © 2018 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-018-7067-4
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2019) 26:8–9 https://doi.org/10.1245/s10434-018-7067-4 EDITORIAL – MELANOMA Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared? 1,2 1,3,4 Hidde M. Kroon, MD, PhD and John F. Thompson, MD, FRACS, FACS 1 2 Melanoma Institute Australia, The University of Sydney, North Sydney, NSW,Australia; Department of General Surgery, The University of Adelaide, Royal Adelaide Hospital, Adelaide, SA, Australia; Discipline of Surgery, The University of Sydney, Sydney, NSW, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia When bulky or numerous local melanoma recurrences or locally recurrent or in-transit metastatic melanoma in-transit melanoma metastases develop in a limb, simple involving a limb. Furthermore, both procedures have local treatment modalities such as excision, cryotherapy, acceptable, usually minor, locoregional postoperative tox- laser ablation, or intralesional injection with Rose Bengal icity with a short hospital stay. Overall responses of (PV-10) or talimogene laherparepvec (T-VEC) are likely to 64–96% can be achieved after ILP, while, in large ILI be ineffective or simply not possible. However, achieving series, overall response rates of 43–84% have been repor- adequate disease control is important in these patients as ted, with somewhat lower complete response rates

Journal

Annals of Surgical OncologySpringer Journals

Published: Nov 21, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off